Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1956 1
1958 2
1963 2
1965 2
1967 2
1968 1
1969 4
1970 4
1971 6
1972 2
1973 1
1975 3
1976 5
1977 2
1978 2
1980 1
1981 5
1982 3
1983 2
1984 2
1985 3
1986 3
1987 6
1988 13
1989 14
1990 9
1991 7
1992 8
1993 7
1994 3
1995 15
1996 22
1997 15
1998 20
1999 12
2000 9
2001 12
2002 5
2003 5
2004 6
2005 10
2006 19
2007 16
2008 22
2009 30
2010 32
2011 52
2012 76
2013 75
2014 65
2015 76
2016 81
2017 77
2018 105
2019 108
2020 149
2021 188
2022 162
2023 162
2024 169
2025 207
2026 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,977 results

Results by year

Filters applied: . Clear all
Page 1
A multimodal generative AI copilot for human pathology.
Lu MY, Chen B, Williamson DFK, Chen RJ, Zhao M, Chow AK, Ikemura K, Kim A, Pouli D, Patel A, Soliman A, Chen C, Ding T, Wang JJ, Gerber G, Liang I, Le LP, Parwani AV, Weishaupt LL, Mahmood F. Lu MY, et al. Among authors: soliman a. Nature. 2024 Oct;634(8033):466-473. doi: 10.1038/s41586-024-07618-3. Epub 2024 Jun 12. Nature. 2024. PMID: 38866050 Free PMC article.
Reply.
El Rayes EN, Habib AM, Soliman AH, Ibrahim OM, El Sawwah KMH. El Rayes EN, et al. Among authors: soliman ah. Retina. 2023 Feb 1;43(2):e8-e9. doi: 10.1097/IAE.0000000000003654. Retina. 2023. PMID: 36695806 No abstract available.
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.
Papp KA, Blauvelt A, Puig L, Ohtsuki M, Beissert S, Gooderham M, Amin AZ, Liu J, Wu T, Azam T, Stakias V, Espaillat R, Sinvhal R, Soliman AM, Pang Y, Chen MM, Lebwohl MG. Papp KA, et al. Among authors: soliman am. J Am Acad Dermatol. 2023 Dec;89(6):1149-1158. doi: 10.1016/j.jaad.2023.07.1024. Epub 2023 Aug 6. J Am Acad Dermatol. 2023. PMID: 37553030 Free article. Clinical Trial.
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study.
Passeron T, Ezzedine K, Hamzavi I, van Geel N, Schlosser BJ, Wu X, Huang X, Soliman AM, Rosmarin D, Harris JE, Camp HS, Pandya AG. Passeron T, et al. Among authors: soliman am. EClinicalMedicine. 2024 May 31;73:102655. doi: 10.1016/j.eclinm.2024.102655. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38873632 Free PMC article.
Growth abnormalities.
De Sanctis V, Soliman AT, Skordis N, authors. Taher A, Porter J, editors. De Sanctis V, et al. Among authors: soliman at. In: Cappellini MD, Farmakis D, Porter J, Taher A, editors. 2021 Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 4th edition. Nicosia (Cyprus): Thalassaemia International Federation; 2023. CHAPTER 7. In: Cappellini MD, Farmakis D, Porter J, Taher A, editors. 2021 Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 4th edition. Nicosia (Cyprus): Thalassaemia International Federation; 2023. CHAPTER 7. PMID: 38683914 Free Books & Documents. Review. No abstract available.
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results.
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Gooderham M, Amin AZ, Wu T, Rubant S, Bialik B, Ashley D, Soliman AM, Chen MM, Blauvelt A. Papp KA, et al. Among authors: soliman am. Am J Clin Dermatol. 2025 Sep;26(5):829-841. doi: 10.1007/s40257-025-00964-6. Epub 2025 Jul 29. Am J Clin Dermatol. 2025. PMID: 40728772 Free PMC article. Clinical Trial.
UK Foot and Ankle Thromboembolism (UK-FATE).
Mangwani J, Houchen-Wolloff L, Malhotra K, Booth S, Smith A, Teece L, Mason LW; UK FATE Collaborative; UK FATE Collaborative; Shaikh R, Alfred W, Okhifun I, Cinar E, Bua N, Vemulapalli K, Acharya A, Gadd R, Money-Taylor J, Kantharaju R, Bhosale A, Bahri S, Broadbent R, Drummond I, Jones N, Shah S, Ravindrarjah T, Yasen Z, Singh K, Al-Habs R, Jeyaseelan L, Habbiba A, Walker T, Dewhurst M, Glasgow N, Eze D, Carter G, Rajan P, Patil V, Amer O, Malik K, Pavanerathan P, Mallick A, Seferiadis I, Currall V, Sadasivan P, Kumar S, Sanjani SR, Ciaccio M, Ayyaswamy B, Prasad P, Anand M, Sunilraj D, Lane S, Prathap S, Kankate R, Aktselis I, Davda K, Vijapur A, Tayyem M, Chau J, Azhar MS, Sturdee S, Hussain H, Sonde S, Luqman MQ, Farooq R, Wells G, Shenolikar A, Simons M, Hodgson P, Thomas R, Stevens S, Elhassan Y, Adeniyi A, Aspinall W, Joseph V, Day M, Tong A, Joyner C, Alzaranky M, Elhassan O, Chhantyal K, Arora A, Abiddin Z, Kucharski R, Ahmad I, Zeb J, Ishaq U, Thomas J, Jain K, Deol R, Faroug R, Johal K, Mordecai S, Argyropouos M, Chawla A, Ibrahim M, Pereira M, Barr L, Julies E, Hill F, Kapoor S, Bailey J, Mukhopadhyay I, Rana S, Tarig H, Qualaghassi M, Seewoonarian S, Rose B, Crate G, … See abstract for full author list ➔ Mangwani J, et al. Among authors: soliman a. Bone Joint J. 2024 Nov 1;106-B(11):1249-1256. doi: 10.1302/0301-620X.106B11.BJJ-2024-0128.R1. Bone Joint J. 2024. PMID: 39481430
Exciting Time for Cancer Education.
Soliman AS. Soliman AS. J Cancer Educ. 2023 Oct;38(5):1401-1402. doi: 10.1007/s13187-023-02360-2. J Cancer Educ. 2023. PMID: 37653125 No abstract available.
1,977 results